Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Relmada Therapeutics (RLMD) Shares Outstanding (2016 - 2026)

Relmada Therapeutics has reported Shares Outstanding over the past 3 years, most recently at $28.5 million for Q1 2014.

  • Quarterly Shares Outstanding rose 21.28% to $28.5 million in Q1 2014 from the year-ago period, while the trailing twelve-month figure was $28.5 million through Feb 2014, up 21.28% year-over-year, with the annual reading at $10.0 million for FY2013, 57.45% down from the prior year.
  • Shares Outstanding was $28.5 million for Q1 2014 at Relmada Therapeutics, roughly flat from $28.5 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $28.5 million in Q4 2013 and troughed at $10.0 million in Q3 2013.
  • The 3-year median for Shares Outstanding is $23.5 million (2012), against an average of $22.9 million.
  • Year-over-year, Shares Outstanding tumbled 57.45% in 2013 and then grew 21.28% in 2014.
  • A 3-year view of Shares Outstanding shows it stood at $23.5 million in 2012, then rose by 21.28% to $28.5 million in 2013, then changed by 0.0% to $28.5 million in 2014.
  • Per Business Quant, the three most recent readings for RLMD's Shares Outstanding are $28.5 million (Q1 2014), $28.5 million (Q4 2013), and $10.0 million (Q3 2013).